Plexiform lesion in severe pulmonary hypertension: association with glomeruloid lesion.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

1. Epigenetic Regulation of Pulmonary Arterial Hypertension-Induced Vascular and Right Ventricular Remodeling: New Opportunities?International journal of molecular sciences · 2020
   Review
2. Pulmonary vascular dysfunction secondary to pulmonary arterial hypertension: insights gained through retrograde perfusion.American journal of physiology. Lung cellular and molecular physiology · 2018
   Article
3. Endothelial hyperpermeability in severe pulmonary arterial hypertension: role of store-operated calcium entry.American journal of physiology. Lung cellular and molecular physiology · 2016
   Article
4. ID3 contributes to the acquisition of molecular stem cell-like signature in microvascular endothelial cells: its implication for understanding microvascular diseases.Microvascular research · 2015
   Article
5. [Aberrant reparative tissue remodeling: histopathology and molecular pathology].Der Pathologe · 2014
   Article
6. Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension.American journal of respiratory and critical care medicine · 2012
   Article
7. Plexiform lesions in pulmonary arterial hypertension composition, architecture, and microenvironment.The American journal of pathology · 2011
   Article
8. GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells.Respiratory research · 2011
   Article
9. Targeting non-malignant disorders with tyrosine kinase inhibitors.Nature reviews. Drug discovery · 2010
   Review
10. Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMalpha) induces the vascular and hemodynamic changes of pulmonary hypertension.American journal of physiology. Lung cellular and molecular physiology · 2009
    Article
11. Phosphoproteomic analysis of lung tissue from patients with pulmonary arterial hypertension.Pulmonary circulation
    Article

Corrections and comments

• Comment on
  Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.1994
• Comment on
  Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth.1999
• Comment on
  Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery.2001

Authors and funding

2 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as